PREZCOBIX PED (DARUNAVIR ETHANOLATE and COBICISTAT)
**Product type:** Human Prescription Drug
**Active ingredient:** COBICISTAT; DARUNAVIR ETHANOLATE
**Strength:** 90; 600 mg/1; mg/1
**Dosage form:** Tablet, For Suspension
**Route:** Oral
**Labeler:** Janssen Products, LP
**Marketing category:** NDA (NDA205395)
**Pharmacologic class:** Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC]
/api/v1/systems/ndc_fda/nodes/59676-577Hierarchy Explorer
Cross-system equivalences0
No cross-system equivalences mapped for this node.